Poolbeg Pharma (POLB), a biopharmaceutical company, said it has received the fully granted patent from the US Patent Office for its Immunomodulator II patent application.
Poolbeg Pharma (POLB), a biopharmaceutical company, said it has received the fully granted patent from the US Patent Office for its Immunomodulator II patent application.
The tug of war continues between the reports in the financial media, and indeed, a Goldman Sachs warning about the London stock market, and the FTSE 100 going to new
Anglo American (AAL) provides an update regarding the unsolicited, non-binding and highly conditional combination proposal from BHP Group Limited.
Tekcapital (TEK) the UK intellectual property investment group, announced that MicroSalt® plc ordinary shares have been admitted to trading on the AIM market of the London Stock Exchange plc and dealings
This week, the AIM All-Share Index displayed a less remarkable performance, although it did experience a rebound on Friday.
Oracle Power (ORCP), an international project developer, updated shareholders on the farm-in by Riversgold Ltd (ASX:RGL) on the Northern Zone Intrusive Hosted Gold Project, which is located 25km east of Kalgoorlie
Trinity Exploration & Production plc (AIM: TRIN), the independent E&P company focused on Trinidad and Tobago, is pleased to provide an update on operations at its Jacobin oil discovery.
There was not much good news on either the political or economic front this week, with perhaps the saving grace being that many stock market participants have decided that hiding
Shares of Trinity Exploration & Production PLC (AIM: TRIN) soared 22% in early trading following the verification of the onshore Trinidad-based Jacobin-1 oil discovery.
It has been a solid week for small caps in general, with the AIM All-Share Index increasing by 1.9% to 765.79p since the start of the week. Positive inflation data
Trinity Exploration & Production plc (AIM: TRIN), the independent E&P company focused on Trinidad and Tobago, provides an update on operations for the three-month period ended 30 June 2023 (“Q2 2023” or “the
The junior market showed strength with the AIM All-Share Index experiencing a 1.3% increase, ending the week at 751.64, which showed notable recovery from recent losses. This uptick was partly